Skip to content

Clinical trials

Terminated Phase 1/2 Lymphoproliferative Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoproliferative Disorders Phase: Phase 1/2 Status: Terminated Clear all

5 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20151
20181
20201
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated5

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AO GENERIUM1
Baylor College of Medicine1
Celgene1
Incyte Corporation1
Oncternal Therapeutics, Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoproliferative Disorders5
Immune System Diseases3
Leukemia3
Lymphatic Diseases3
Lymphoma3
Precursor Cell Lymphoblastic Leukemia-Lymphoma3
Hematologic Diseases2
Immunoproliferative Disorders2
Leukemia, Myeloid, Acute2
Lymphoma, Non-Hodgkin2

Trials

Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.